What is the catalog number for Trifluorothymine-13C,15N2?

The catalog number for Trifluorothymine-13C,15N2 is CS-T-63076.

What sizes are available for Trifluorothymine-13C,15N2?

Trifluorothymine-13C,15N2 is available in the following size(s): 1 Each.

Is Trifluorothymine-13C,15N2 in stock?

Trifluorothymine-13C,15N2 is currently made to order / not held in immediate stock. Contact us for lead time.

Where can I find the safety data sheet (SDS/MSDS) for Trifluorothymine-13C,15N2?

The safety data sheet for Trifluorothymine-13C,15N2 is available here: https://msds_v1.clearsynth.com/msds.asp?catnumber=CS-T-63076.

Trifluorothymine-13C,15N2

Trifluorothymine-13C,15N2 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Trifluridine. The product is supplied by Clearsynth under CAT No. CS-T-63076. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

"Trifluorothymine-13C,15N2 is an isotopic analog of Trifluorothymine, an antitumor and antiviral agent. Trifluorothymine was found in patients' urine as a metabolite of Trifluorothymidine as cancer treatment."

CAS Number

1397206-73-3

Synonyms

Trifluorothymine-13C,15N2

Molecular Formula

C 413 CH 3 F 315 N 2 O 2

Molecular Weight

183.06

Additionnal Information

Trifluorothymine-13C,15N2 is supplied with detailed characterization data compliant with regulatory guideline. Trifluorothymine-13C,15N2 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Trifluridine.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

"Trifluorothymine-13C,15N2 is an isotopic analog of Trifluorothymine, an antitumor and antiviral agent. Trifluorothymine was found in patients' urine as a metabolite of Trifluorothymidine as cancer treatment."